KLOW is a single 80 mg lyophilized vial containing four compounds: GHK-Cu, BPC-157, TB-500 and KPV. GHK-Cu is the predominant component; exact proportions for the vial you receive are printed on that lot's certificate of analysis.

Each component is assayed by HPLC-UV at 220 nm for purity under USP , identity is confirmed by FTIR under USP , and bacterial endotoxin is measured by gel-clot LAL under USP . Testing is performed by an accredited third-party laboratory, not in house.

Why are these four compounds combined?

Each has been studied in a different part of the matrix-remodelling and inflammatory-signalling literature — copper transport and matrix remodelling, angiogenic and gastrointestinal models, actin sequestration, and melanocortin-pathway inflammatory signalling. Combining them into one vial is a formulation convenience for researchers designing multi-component protocols; it is not evidence of a combined effect.

Is KLOW for human use?

No. KLOW is supplied for research use only and is not for human or veterinary use.

Sequence	GHK · Cu²⁺
Length	3 residues + Cu²⁺
Formula	C₁₄H₂₃N₆O₄Cu
Mol. weight	402.93 g/mol
CAS	89030-95-5
PubChem	71587328

Cellular

GHK-Cu

GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine (GHK), a small endogenous peptide identified as a circulating factor whose plasma concentration declines with age.

Molecular structure

Sequence GHK · Cu²⁺

What it has been studied for

Research interest spans connective-tissue remodeling, antioxidant gene expression modulation, and stem-cell signaling. The peptide has been studied as a tool compound in dermal fibroblast cultures, hair-follicle research, and in-vitro wound-healing models.

References

Citations for this compound are being verified against the primary sources before they are listed. Nothing appears here until it has been checked.

Back to GHK-Cu

For Research Use Only. Not for human or veterinary use.